JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FULLER, R. W.
Right arrow Articles by MOLLOY, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FULLER, R. W.
Right arrow Articles by MOLLOY, B. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHETAMINE
*CHLORINE
*FLUORINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 184, Issue 1, 278-284, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF beta,beta-DIFLUORO SUBSTITUTION ON THE DISPOSITION AND PHARMACOLOGICAL EFFECTS OF 4-CHLOROAMPHETAMINE IN RATS

RAY W. FULLER 1, HAROLD D. SNODDY 1, and BRYAN B. MOLLOY 1

1 The Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

beta,beta-Difluoro-4-chloroamphetamine has a pK of 6.8 compared to 9.3 for 4-chloroamphetamine. At physiological pH, the difluoro compound thus exists primarily as a neutral molecule, whereas the parent drug exists as a cation. The tissue distribution of the two drugs when they were injected into rats was different. Whereas the relative concentration of 4-chloroamphetamine in tissues was kidney > lung > brain > spleen > liver > heart > epididymal fat, the difluoro compound localized chiefly in epididymal fat and was present in all other tissues in concentrations lower than those of 4-chloroamphetamine. The distribution of 4-chloroamphetamine between particulate and soluble fractions of brain was altered only slightly by the difluoro substitution. The difluoro compound disappeared from whole body of rats with shorter half-life (1.3 hours) than that of 4-chloroamphetamine (7.5 hours). The difluoro compound was excreted unchanged into the urine to a much smaller degree than was 4-chloroamphetamine. These results suggest the difluoro compound is metabolized more rapidly and to a greater extent in rats than is 4-chloroamphetamine. Higher doses of the difluoro compound were required to produce drug levels in brain equal to those of 4-chloroamphetamine and the levels of the difluoro compound fell more rapidly. There was less hyperthermia and central nervous system stimulation caused by the difluoro compound even on the basis of comparable drug levels in brain. beta,beta-Difluoro-4-chloroamphetamine reduced 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels in brain as did 4-chloroamphetamine, but because of the altered tissue distribution and more rapid disappearance of the difluoro compound, its effect on brain 5-hydroxyindoles was transient and occurred only at higher doses than with 4-chloroamphetamine. Thus, substitution of two fluorines on the beta carbon of 4-chloroamphetamine, probably because of the lowered pK, markedly altered the physiologic disposition and, hence, the pharmacologic effects of the drug.

Submitted on June 19, 1972
Accepted on October 2, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.